These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8712391)

  • 1. The effect of esmolol pretreatment on the incidence of regional wall motion abnormalities during electroconvulsive therapy.
    O'Connor CJ; Rothenberg DM; Soble JS; Macioch JE; McCarthy R; Neumann A; Tuman KJ
    Anesth Analg; 1996 Jan; 82(1):143-7. PubMed ID: 8712391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of esmolol and labetalol to attenuate hyperdynamic states after electroconvulsive therapy.
    Castelli I; Steiner LA; Kaufmann MA; Alfillé PH; Schouten R; Welch CA; Drop LJ
    Anesth Analg; 1995 Mar; 80(3):557-61. PubMed ID: 7864425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy.
    Howie MB; Black HA; Zvara D; McSweeney TD; Martin DJ; Coffman JA
    Anesth Analg; 1990 Oct; 71(4):384-8. PubMed ID: 1975995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esmolol bolus and infusion attenuates increases in blood pressure and heart rate during electroconvulsive therapy.
    Kovac AL; Goto H; Arakawa K; Pardo MP
    Can J Anaesth; 1990 Jan; 37(1):58-62. PubMed ID: 1967227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining the dose range for esmolol used in electroconvulsive therapy hemodynamic attenuation.
    Howie MB; Hiestand DC; Zvara DA; Kim PY; McSweeney TD; Coffman JA
    Anesth Analg; 1992 Nov; 75(5):805-10. PubMed ID: 1358003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of esmolol on ST-segment depression and arrhythmias after electroconvulsive therapy.
    Zvara DA; Brooker RF; McCall WV; Foreman AS; Hewitt C; Murphy BA; Royster RL
    Convuls Ther; 1997 Sep; 13(3):165-74. PubMed ID: 9342132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does dobutamine improve ventricular function in dogs with regional myocardial dysfunction?
    Strum DP; Pinsky MR
    Anesth Analg; 2002 Jul; 95(1):19-25, table of contents. PubMed ID: 12088936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two esmolol bolus doses on the haemodynamic response and seizure duration during electroconvulsive therapy.
    Kovac AL; Goto H; Pardo MP; Arakawa K
    Can J Anaesth; 1991 Mar; 38(2):204-9. PubMed ID: 1673645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landiolol and esmolol prevent tachycardia without altering cerebral blood flow.
    Saito S; Nishihara F; Akihiro T; Nishikawa K; Obata H; Goto F; Yuki N
    Can J Anaesth; 2005 Dec; 52(10):1027-34. PubMed ID: 16326671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beat-to-beat hemodynamic monitoring during electroconvulsive therapy.
    Geersing PG; Bulte CS; Viersen VA; Stek ML; Bouwman RA; Boer C; Loer SA
    J ECT; 2011 Sep; 27(3):189-91. PubMed ID: 21206372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of esmolol, nicardipine, or their combination to blunt hemodynamic changes after laryngoscopy and tracheal intubation.
    Atlee JL; Dhamee MS; Olund TL; George V
    Anesth Analg; 2000 Feb; 90(2):280-5. PubMed ID: 10648307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose esmolol bolus reduces seizure duration during electroconvulsive therapy: a double-blind, placebo-controlled study.
    van den Broek WW; Leentjens AF; Mulder PG; Kusuma A; Bruijn JA
    Br J Anaesth; 1999 Aug; 83(2):271-4. PubMed ID: 10618942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamic effects of dexmedetomidine and esmolol in electroconvulsive therapy: a retrospective comparison.
    Aydogan MS; Yücel A; Begec Z; Colak YZ; Durmus M
    J ECT; 2013 Dec; 29(4):308-11. PubMed ID: 23774056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of four pretreatment regimes on hemodynamics during electroconvulsive therapy: A double-blind randomized controlled crossover trial.
    Parikh DA; Garg SN; Dalvi NP; Surana PP; Sannakki D; Tendolkar BA
    Ann Card Anaesth; 2017; 20(1):93-99. PubMed ID: 28074804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function.
    Rivera FA; Lapid MI; Sampson S; Mueller PS
    J ECT; 2011 Sep; 27(3):207-13. PubMed ID: 21865957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of the cardiovascular and neuroendocrine response to electroconvulsive therapy: I. Effectiveness of pretreatment regimens on hemodynamics.
    Weinger MB; Partridge BL; Hauger R; Mirow A
    Anesth Analg; 1991 Nov; 73(5):556-62. PubMed ID: 1952135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of esmolol to control bleeding and heart rate during electroconvulsive therapy in a patient with an intracranial aneurysm.
    Kolano JE; Chhibber A; Calalang CC
    J Clin Anesth; 1997 Sep; 9(6):493-5. PubMed ID: 9278838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of esmolol pretreatment on EEG seizure morphology in RUL ECT.
    McCall WV; Zvara D; Brooker R; Arias L
    Convuls Ther; 1997 Sep; 13(3):175-80. PubMed ID: 9342133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of esmolol and labetalol to attenuate haemodynamic responses after electroconvulsive therapy.
    Shrestha S; Shrestha BR; Thapa C; Pradhan SN; Thapa R; Adhikari S
    Kathmandu Univ Med J (KUMJ); 2007; 5(3):318-23. PubMed ID: 18604047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ECT in the presence of intracranial aneurysm.
    Najjar F; Guttmacher LB
    J ECT; 1998 Dec; 14(4):266-71. PubMed ID: 9871849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.